Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00126906
What this trial is testing

Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi

Who this might be right for
Malaria, FalciparumHIV Infections
Centers for Disease Control and Prevention 700
Post-approval studies (Phase 4)Study completedNCT00627055
What this trial is testing

Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 200
Post-approval studies (Phase 4)Study completedNCT03855176
What this trial is testing

Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients

Who this might be right for
Hepatitis AHuman Immunodeficiency VirusVaccine Response Impaired
National Taiwan University Hospital 153
Not applicableStudy completedNCT04958889
What this trial is testing

COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)HIV
Johns Hopkins University 392
Testing effectiveness (Phase 2)Study completedNCT01222338
What this trial is testing

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

Who this might be right for
Tuberculosis
Lisichansk Regional Tuberculosis Dispensary 123
Testing effectiveness (Phase 2)Study completedNCT01022476
What this trial is testing

Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients

Who this might be right for
HIV InfectionLiver FailureEvidence of Liver Transplantation
ANRS, Emerging Infectious Diseases 14
Large-scale testing (Phase 3)Study completedNCT03682848
What this trial is testing

Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents

Who this might be right for
HIV Infections
ViiV Healthcare 32
Testing effectiveness (Phase 2)Ended earlyNCT00122577
What this trial is testing

Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 50
Testing effectiveness (Phase 2)Study completedNCT00002361
What this trial is testing

Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 30
Large-scale testing (Phase 3)Study completedNCT05601128
What this trial is testing

A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA

Who this might be right for
HIV-1-infectionHIV InfectionsHIV I Infection
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 12
Testing effectiveness (Phase 2)Looking for participantsNCT05674656
What this trial is testing

Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics

Who this might be right for
HIV Infections
ViiV Healthcare 20
Testing effectiveness (Phase 2)Study completedNCT00142337
What this trial is testing

One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine

Who this might be right for
HIV Infections
Institut de Recherche pour le Developpement 244
Early research (Phase 1)Study completedNCT01264445
What this trial is testing

Safety and Immunogenicity Study of 2 Investigational Preventive HIV Vaccines

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 147
Testing effectiveness (Phase 2)Study completedNCT03031912
What this trial is testing

African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola

Who this might be right for
Ebola
Canadian Immunization Research Network 251
Testing effectiveness (Phase 2)Study completedNCT00001061
What this trial is testing

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 167
Testing effectiveness (Phase 2)Active Not RecruitingNCT03519464
What this trial is testing

Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia

Who this might be right for
Idiopathic CD4 T Cell Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 54
Not applicableStudy completedNCT04125784
What this trial is testing

Lipid Profile and Diabetes Mellitus in People With HIV

Who this might be right for
HIV InfectionsDyslipidemiasDiabetes Mellitus+1 more
Moritz Oberndorfer 450
Not applicableStudy completedNCT02999334
What this trial is testing

HIV With Innovative Group Antenatal Care in Two African Countries

Who this might be right for
Prenatal Care
University of Illinois at Chicago 218
Large-scale testing (Phase 3)Study completedNCT00750009
What this trial is testing

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Case Comprehensive Cancer Center 583
Early research (Phase 1)Study completedNCT00002098
What this trial is testing

Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients

Who this might be right for
HIV Infections
AJI Pharma USA 50
Next Page